Progress to Therapy 2012

P₂T 2012 is a three day conference designed to help accelerate the speed with which new stem cell and regenerative medicine ideas become products that bring benefits to patients. The first day will focus on therapies for cardiovascular disease, whilst days two and three will examine a range of Advanced Therapeutic Medicinal Products (ATMPs) and address key issues in clinical trials, regulation, imaging, manufacturing, reimbursement and business models. Visit our P2T 2012 website for the programme, confirmed international speaker list and conference details.

The meeting will attract 250 - 300 key thought leaders from across the biological medicines sector in the UK and Europe representing both companies and academic groups who are committed to the translation and development of regenerative medicine research.

This three day conference will cover cardiovascular disease, diabetes, liver disease, cancer, muscular skeletal disease and the central nervous system as well as encouraging cross disciplinary knowledge exchange with a range of workshops run by global experts.